Aspirin use among adults aged 40 and older in the United States: results of a national survey
about
A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.Use of antithrombotic agents among U.S. stroke survivors, 2000-2006Aspirin for primary cardiovascular prevention: when is it worth the risks?Risk assessment and aspirin use in Asian and Western populations.Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland.Aspirin overutilization for the primary prevention of cardiovascular disease.Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis.Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?The role of aspirin in the prevention of cardiovascular disease.Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA)Identifying opportunities to improve aspirin utilization for the primary prevention of cardiovascular disease in a regional health care system.Potential contribution of aspirin to cancer control programmes.Aspirin: pharmacology and clinical applicationsAspirin and multiple sclerosisAspirin use and cardiovascular events in social networks.Providing young women with credible health information about bleeding disorders.Public opinion concerning residential sprinkler systems for 1- and 2-family homesAspirin Use for the Primary Prevention of Myocardial Infarction Among Men in North Carolina, 2013.Family practice patients' use of acetylsalicylic acid for cardiovascular disease prevention.Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart SurveyPotential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.Aspirin for primary prevention: do potential benefits outweigh the risks?Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding.The impact of antiplatelet medication on hand and wrist surgery.Advancing aspirin utilization: a review of clinical and systems-based interventions.Review article: Microscopic colitis--lymphocytic, collagenous and 'mast cell' colitis.Review of the microscopic colitides.Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?Aspirin use and mortality in two contemporary U.S. cohorts.Decreased colorectal cancer and adenoma risk in patients with microscopic colitis.Aspirin use and the risk of cholangiocarcinoma.Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study).Hand and wrist surgery without suspending warfarin or oral antiplatelet - systematic review.Clothing Flammability and Burn Injuries: Public Opinion Concerning an Overlooked, Preventable Public Health Problem.Aspirin for primary prevention: a challenging decision.The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure.An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
P2860
Q33622632-51F24BEB-2B86-47C0-A613-80E6BA88694EQ33640489-251F139B-1DFC-42E0-8D9C-48088711A6B8Q33774734-E394AA33-4C7C-4ADD-9124-11082FDF8D1EQ34245212-DB7F8988-A9F2-4ED7-BBC1-6A91363C7748Q34462760-C97FCDCA-B61E-4E39-9427-6C45D5E5A62FQ34657167-D2822D5A-A527-4376-9844-F4365AF3E546Q34790218-B5115F1B-080B-45C7-9E4F-908073DF15DFQ35040366-8DCAEFE3-CD12-4816-85E8-5290AE2B372BQ35049359-2F81B283-5493-402A-8EEC-2EED892BFE65Q35482883-311060D0-80F7-4BFC-AAB5-F67B974372ADQ35551012-831B2CD7-4DCA-4F98-ABB6-D354A4898D0FQ35602238-E3F442B9-A31D-4D56-9394-726777824A41Q35608778-416B8C96-44F0-4337-9210-D5923B7B8684Q35678040-AA7596A0-D34E-4900-B6FA-AE529B53B059Q35818810-DBDE842F-A0A3-4DCA-BD2B-CB9BFD58EAE7Q35825745-B14712AB-9597-4B41-95B2-0F3EB6A050C8Q36249276-8B01DE26-E550-452A-8D67-83FE29CD0553Q36305884-F3AA2330-C9ED-491E-93BB-C112868D2FA9Q36564342-1EF90BE7-76AB-44B5-86AD-5B0A10947863Q36836426-6BB5F93B-5514-4A42-8043-CAC661CF7CEFQ37392002-A3485A82-5C66-4FDE-962F-BC0982354131Q37542357-A9CB75E8-153B-454E-821C-353769DBFB52Q37625235-4B6166EC-45E3-46A9-AD80-E754A1A510F5Q37707869-4A869243-A007-40C5-A60A-02E79E719939Q37760669-2D8E37AD-537B-42CD-840F-2F73F8124BD2Q37872335-D665F1F4-30BD-4D51-BB62-0F000B75C0B8Q37902953-6166157B-00B2-4109-B101-4F208EBA9AAAQ38189104-3A0F2D18-09D8-4EAB-A11C-A0391783E8E8Q38597861-A7667DA5-FED3-43F0-B4C1-98F20A3ED8E7Q39716838-32535015-DDF8-4CA2-B12C-FD36A90BC898Q40873283-9E8F30AE-9B7A-4203-95FA-1A5F3BFFE586Q41549676-59103998-8DE6-4020-9164-2E2DBBE21497Q41603445-FFF0FC18-013E-4125-98FC-93A560653DFCQ41697240-67CAD8F9-ECA4-4FDC-9654-DB6D42336F17Q43123151-12396F31-4DCA-4798-910B-70B03BD0EA3EQ44290853-CCA26D8D-B307-4D3A-97B5-E9F9E8822ADAQ47169317-E8F34C96-D82B-436A-90E1-AF67F1C60061Q47834948-8886F494-67B3-4873-B0CE-84E9D6661A60Q54637252-C3A4E900-CF5E-4832-A3C3-CFB8839EB648Q55312563-CEF280BA-2332-4F7A-88D2-CA4324934844
P2860
Aspirin use among adults aged 40 and older in the United States: results of a national survey
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aspirin use among adults aged ...... : results of a national survey
@ast
Aspirin use among adults aged ...... : results of a national survey
@en
Aspirin use among adults aged ...... : results of a national survey
@nl
type
label
Aspirin use among adults aged ...... : results of a national survey
@ast
Aspirin use among adults aged ...... : results of a national survey
@en
Aspirin use among adults aged ...... : results of a national survey
@nl
prefLabel
Aspirin use among adults aged ...... : results of a national survey
@ast
Aspirin use among adults aged ...... : results of a national survey
@en
Aspirin use among adults aged ...... : results of a national survey
@nl
P2093
P1476
Aspirin use among adults aged ...... : results of a national survey
@en
P2093
George K Anderson
Hugh H Tilson
Katherine Binns
Steven M Weisman
P304
P356
10.1016/J.AMEPRE.2007.01.010
P407
P577
2007-05-01T00:00:00Z